Molina Healthcare Q1 Earnings Beat on Growing Membership It has been about a month since the last earnings report for Molina (MOH) . Shares have lost about 3.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Molina due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalyst ...

Molina Healthcare, Inc. (MOH) reported first-quarter 2024 adjusted earnings per share (EPS) of $5.73, which beat the Zacks Consensus Estimate by 5%. However, the bottom line dipped 1.4% year over year.Total revenues amounted to $9.9 billion, which improved 21.9% year over year. Also, the top line outpaced the consensus mark by 4.3%.The quarterly results were aided by membership growth in each of the business lines of Molina Healthcare. This, in turn, drove premiums, the most significant contributor to a hea ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State ...

Molina (MOH) reported $9.93 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 21.9%. EPS of $5.73 for the same period compares to $5.81 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $9.52 billion, representing a surprise of +4.32%. The company delivered an EPS surprise of +4.95%, with the consensus EPS estimate being $5.46.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Revenue Growth - Revenue increased by 15% year-over-year, driven by strong performance in the North American market [1]. - The company achieved a record-breaking revenue of $5 billion in Q4, surpassing market expectations [2]. - Revenue from the EMEA region grew by 10%, contributing significantly to overall growth [3]. Cost Management - Operating expenses were reduced by 8% due to efficient cost-cutting measures implemented in Q3 [1]. - The company successfully lowered its production costs by 12% through supply chain optimization [4]. - General and administrative expenses remained flat, reflecting strict budget controls [2]. Profitability - Net profit margin improved to 18%, up from 15% in the previous quarter [1]. - The company reported a net income of $1.2 billion, a 20% increase compared to the same period last year [3]. - Gross profit margin expanded to 40%, driven by higher sales volumes and better pricing strategies [4]. Market Expansion - The company entered two new markets in Asia, which are expected to contribute to future revenue growth [2]. - A new distribution center was opened in Europe to support increased demand in the region [3]. - Strategic partnerships were formed with local suppliers in South America to enhance market penetration [4]. Product Innovation - Launched three new products in the tech segment, which received positive market feedback [1]. - R&D investment increased by 15%, focusing on next-generation technologies [2]. - The company introduced a new line of eco-friendly products, aligning with sustainability goals [3]. Shareholder Returns - The board approved a 10% increase in dividend payouts, reflecting strong financial performance [1]. - Share buybacks totaled $500 million, aimed at enhancing shareholder value [4]. - Earnings per share (EPS) rose to $2.50, up from $2.10 in the previous quarter [2]. Operational Efficiency - Production efficiency improved by 15% due to the implementation of advanced manufacturing technologies [1]. - The company reduced its inventory turnover days from 45 to 35, enhancing cash flow [3]. - Employee productivity increased by 10%, driven by new training programs and process improvements [4]. Sustainability Initiatives - The company achieved a 20% reduction in carbon emissions, surpassing its sustainability target [1]. - Renewable energy usage increased to 30% of total energy consumption, up from 25% last year [2]. - A new recycling program was introduced, aiming to reduce waste by 15% annually [3]. Customer Satisfaction - Customer satisfaction scores improved to 90%, the highest in the company's history [1]. - The company launched a new customer loyalty program, which has already attracted 100,000 members [2]. - Net Promoter Score (NPS) increased by 5 points, reflecting stronger customer advocacy [4]. Risk Management - The company strengthened its cybersecurity measures, reducing the risk of data breaches by 30% [1]. - A new risk management framework was implemented, improving overall operational resilience [3]. - Insurance coverage was expanded to mitigate potential financial losses from natural disasters [4]. Workforce Development - Employee retention rates improved to 85%, up from 80% last year [1]. - The company invested $10 million in employee training programs, focusing on skill development [2]. - Diversity and inclusion initiatives were expanded, resulting in a 15% increase in workforce diversity [3].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ________ TO ________ Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 (State or ot ...

Molina Healthcare, Inc. (NYSE:MOH) Q3 2023 Earnings Conference Call October 26, 2023 8:00 AM ET Company Participants Joe Krocheski – Senior Vice President-Investor Relations Joe Zubretsky – President and Chief Executive Officer Mark Keim – Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research Kevin Fischbeck – Bank of America Nathan Rich – Goldman Sachs Justin Lake – Wolfe Research Calvin Sternick – JPMorgan Stephen Baxter – Wells Fargo Scott Fidel – Stephens A.J. Rice – UBS Ge ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) In ...

Financial Data and Key Metrics Changes - The company reported adjusted earnings per diluted share of $5.65 for Q2 2023, representing a 24% year-over-year growth on $8 billion of premium revenue [37] - The consolidated Medical Care Ratio (MCR) for Q2 was 87.5%, reflecting strong medical cost management and at the low end of the long-term target range [20][37] - The adjusted pre-tax margin was 5.3% for Q2, with a year-to-date adjusted pre-tax margin of 5.4% [12][15] Business Line Data and Key Metrics Changes - Medicaid, the flagship business, had an MCR of 88.3% for Q2, consistent with expectations and long-term targets, with year-to-date MCR at 88.4% [20][38] - The Medicare segment reported an MCR of 89.2%, slightly above the long-term target range, with increased utilization in outpatient and professional services [13][46] - The Marketplace business achieved an MCR of 73.7% for Q2, reflecting successful pricing strategies and a return to target margins [21][39] Market Data and Key Metrics Changes - The company experienced a decline of 93,000 Medicaid members during Q2, which was within expectations due to the initial impact of redeterminations [41] - The company anticipates a premium impact of approximately $1.6 billion from members disenrolling, with an expected earnings impact of about $1 per share [27] Company Strategy and Development Direction - The company aims to grow premiums at 13% to 15% through current footprint expansion, strategic initiatives, and accretive acquisitions, targeting $46 billion in premium revenue by 2026 [42] - The acquisition of Bright HealthCare's California Medicare business is expected to add approximately $1.8 billion in premium revenue, with no earnings contribution in the first year [18][43] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term financial targets, with a projected annual earnings per share growth rate of 15% to 18% [19] - The company has not observed any emerging trends that would change membership or financial outlooks during the early stages of the Medicaid redetermination process [25] Other Important Information - The company increased its 2023 adjusted earnings guidance by $0.50 to at least $20.75 per share, driven by strong Q2 performance and higher expected investment income [24][40] - The company maintains a low leverage position with a debt-to-cap ratio of 40% and a trailing 12-month EBITDA ratio of 1.6 times [23] Q&A Session Summary Question: Can you discuss the discussions with states regarding rates and the impact from reverifications? - Management indicated that discussions are ongoing with states about potential rate adjustments due to acuity shifts, with most states committed to ensuring rates remain actuarially sound [54][78] Question: What was the actual benefit from the 2022 final risk adjustment true-up? - Management noted that the risk adjustment data validation impacts margins, and the benefit was cut in half due to margin retention [58][59] Question: How are you thinking about reconnects and disenrollments? - Management expects a high rate of reconnects for members disenrolled for procedural reasons, with states allowing 90 to 120 days for members to reestablish eligibility [90][91] Question: What is the timeline for reaching run rate on the Bright Health acquisition? - Management stated that the timeline for achieving target margins on the Bright acquisition is expected to be by the end of the second year post-acquisition [121] Question: How do you view the marketplace growth versus margin strategy for 2024? - Management reiterated that the strategy remains to achieve mid-single-digit margins while allowing for measured growth in the Marketplace segment [102][103]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State ...